Press Releases NeuBase Therapeutics, Inc.

Equities

NBSE

US64132K2015

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.4396 ^USD	-0.54%		+2.23%	-40.60%

Mar. 26	Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	MT
Mar. 26	US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq	Apr. 05	AQ
NeuBase Therapeutics : Material Event - Form 8-K	23-10-20	PU
Thinking about buying stock in Navios Maritime Holdings, Biodexa Pharmaceuticals, Iovance Biotherapeutics, Neubase Therapeutics, or Iris Energy?	23-09-18	PR
Thinking about buying stock in Immunitybio, Aurora Cannabis, Elutia, Canopy Growth, or Neubase Therapeutics?	23-09-11	PR
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder	23-09-08	AQ
SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE	23-09-06	PR
NeuBase Therapeutics to Explore Strategic Alternatives	23-08-03	AQ
NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors™ are Non-Immunogenic, Opening the Door to Redosing	23-06-29	AQ
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules	23-06-28	AQ
NeuBase Announces 1-for-20 Reverse Stock Split	23-06-14	AQ
NeuBase to Participate in Jefferies Healthcare Conference	23-05-24	AQ
NEUBASE THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-22	AQ
NeuBase Announces Positive Preclinical Data Supporting the Capabilities of Stealth Editors™	23-05-22	AQ
NeuBase Announces Formation of Gene Editing Advisory Board	23-05-16	AQ
NeuBase: Fiscal Q2 Earnings Snapshot	23-05-11	AQ
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023	23-05-11	AQ
NeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting	23-05-02	AQ
NEUBASE THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)	23-04-24	AQ
NEUBASE THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-03-29	AQ
NeuBase: Fiscal Q1 Earnings Snapshot	23-02-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NeuBase Therapeutics, Inc.

Equities

NBSE

US64132K2015

Press Releases

Filters